Evidence map›Paper›PMID 31384765›Full record

ReviewBMC chemistry2019

A comprehensive review on biological activities of oxazole derivatives.

Saloni Kakkar, Balasubramanian Narasimhan

Open access · goldAbstract readReview
In one paragraph

Review in BMC chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 211 citations in OpenAlex.

  1. Review
  2. Review
  3. One-pot divergent synthesis of 5-arylmethyl oxazoles and polyacenes from propargylic amides and arynes.Organic chemistry frontiers : an international journal of organic chemistry · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Oxazole-Based Molecules: Recent Advances on Biological Activities.Current topics in medicinal chemistry · 2026
    Review
  10. Article
  11. Article
  12. Crystal structure and Hirshfeld surface analysis of an etoxazole metabolite designated R4.Acta crystallographica. Section E, Crystallographic communications · 2025
    Article
  13. Review
  14. Review
  15. Crystal structure and Hirshfeld-surface analysis of the pesticide etoxazole.Acta crystallographica. Section E, Crystallographic communications · 2025
    Article
  16. Review
  17. Article
  18. Synthesis of Oxazoles Containing CFMolecules (Basel, Switzerland) · 2024
    Article
  19. Review
  20. Crystal structure and Hirshfeld-surface analysis of an etoxazole metabolite designated R13.Acta crystallographica. Section E, Crystallographic communications · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Saloni KakkarFaculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001 India.
Balasubramanian NarasimhanFaculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001 India.ORCID 0000-0002-9627-094X
Maharshi Dayanand University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The utility of oxazole as intermediates for the synthesis of new chemical entities in medicinal chemistry have been increased in the past few years. Oxazole is an important heterocyclic nucleus having a wide spectrum of biological activities which drew the attention of researchers round the globe to synthesize various oxazole derivatives and screen them for their various biological activities. The present review article aims to review the work reported on therapeutic potentials of oxazole scaffolds which are valuable for medical applications during new millennium.

Indexed as

AnticancerAntimicrobialAntitubercularOxazole derivatives

Identifiers

PMID31384765
PMCPMC6661760
OpenAlexW2926174189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.